Stockscreener 앱 받기
4.59
3.97%
-0.19
시간 외 거래:
4.63
0.04
+0.87%
전일 마감가:
$4.78
열려 있는:
$4.78
하루 거래량:
429.24K
Relative Volume:
0.62
시가총액:
$164.55M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-15.00%
1개월 성능:
-20.73%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$4.50
$4.89
1주일 범위
$4.50
$5.44
52주 변동 폭
$3.85
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
명칭
Bioage Labs Inc
전화
510-806-1445
주소
1445A SOUTH 50TH STREET, RICHMOND
BIOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
4.59 | 164.55M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
170.90 | 77.10B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.47 | 42.82B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.39 | 42.45B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.73 | 20.09B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
151.82 | 15.37B | 2.24B | 385.90M | 440.10M | 3.73 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-21 | 개시 | Citigroup | Buy |
| 2024-10-21 | 개시 | Jefferies | Buy |
| 2024-10-21 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioage Labs Inc 주식(BIOA)의 최신 뉴스
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing
Kessler Topaz Meltzer & Check, LLP Reminds BIOA Investors of March 10, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm - GlobeNewswire Inc.
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel - The Bakersfield Californian
2025-01-31 | Investors Who Lost Money on BioAge Labs, Inc. (BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BioAge Labs (BIOA) Faces Securities Class Action On Behalf - GlobeNewswire
2025-01-31 | BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-01-31 | Faruqi & Faruqi Reminds BioAge Labs Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA LAWSUIT ALERT: BioAge Sued after Stock Drops 76% – - GlobeNewswire
Class Action Filed Against BioAge Labs, Inc. (BIOA)March 10, 2025 Deadline to JoinContact Levi & Korsinsky - GuruFocus.com
2025-01-30 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – BIOA - GlobeNewswire
2025-01-30 | Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
DEADLINE ALERT for RVNC, REGN, and BIOA: The Law Offices of - GlobeNewswire
2025-01-30 | Shareholders That Lost Money on BioAge Labs, Inc. (BIOA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:BIOA | Press Release - Stockhouse Publishing
The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire
BioAge Lab - The Pharma Letter
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
BioAge Labs, Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire
2025-01-29 | Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
BioAge drops obesity drug; Akero, 89bio cash in on MASH data - BioPharma Dive
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - GlobeNewswire
Bioage nominates NLRP3 inhibitor as development candidate - BioWorld Online
BioAge rings the changes after azelaprag failure - The Pharma Letter
BIOA COURT ALERT: The BioAge Labs Class Action Deadline is - GlobeNewswire
BIOA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
2025-01-28 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming DeadlinesBIOA - PR Newswire
Kessler Topaz Meltzer & Check, LLP Encourages BioAge Labs, Inc. Investors with Losses to Contact the Firm - GuruFocus.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Newsfile
2025-01-28 | Investors who lost money on BioAge Labs, Inc. (BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel - The Bakersfield Californian
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire
BioAge Labs Terminates Azelapra Development -January 28, 2025 at 10:36 am EST - Marketscreener.com
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs - The Manila Times
Bioage Labs, Inc. Announces Company Updates on APJ, NLRP3, and Platform Programs - Marketscreener.com
Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - Morningstar
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
BIOA SHAREHOLDER NEWS: BioAge Labs Investors are Alerted of - GlobeNewswire
2025-01-27 | Investors who lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with - EIN News
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit – BIOA - GlobeNewswire
Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIOA - Stockhouse Publishing
2025-01-27 | Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Shareholders that lost money on BioAge Labs, Inc.(BIOA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing - GlobeNewswire
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - GlobeNewswire Inc.
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securi - GuruFocus.com
2025-01-26 | Shareholders that lost money on BioAge Labs, Inc.(BIOA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:BIOA | Press Release - Stockhouse Publishing
Bioage Labs Inc (BIOA) 재무 분석
Bioage Labs Inc (BIOA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.19%
0.06%
자본화:
|
볼륨(24시간):